Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71,674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network.
Sun X, Klingbeil O, Lu B, Wu C, Ballon C, Ouyang M, Wu XS, Jin Y, Hwangbo Y, Huang YH, Somerville TDD, Chang K, Park J, Chung T, Lyons SK, Shi J, Vogel H, Schulder M, Vakoc CR, Mills AA. Sun X, et al. Among authors: park j. Nature. 2023 Jan;613(7942):195-202. doi: 10.1038/s41586-022-05551-x. Epub 2022 Dec 21. Nature. 2023. PMID: 36544023 Free PMC article.
Tetragonia tetragonioides extract prevented high-fat diet-induced obesity and changed hepatic and adipose transcriptomic signatures in C57BL/6J male mice.
Oh HR, Park YH, Hong HR, Kim HJ, Park J, Han Y, Ko SG, Shin EC, Kim TG, Cho HT, Pan JH, Shin HR, Shim YY, Reaney MJT, Cho TJ, Hong JY, Kim YJ, Han BK, Lee GJ, Lee K, Do SG, Kim JK. Oh HR, et al. Among authors: park j. Biosci Biotechnol Biochem. 2025 Jan 11:zbaf001. doi: 10.1093/bbb/zbaf001. Online ahead of print. Biosci Biotechnol Biochem. 2025. PMID: 39799382
Corrigendum to "Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer" [Biomed. Pharmacother. 182 (2025) 117795].
Lee Y, Lee YY, Park J, Maksakova A, Seo D, Kim J, Yeom JE, Kim Y, Kim CH, Ryoo R, Kim SN, Park J, Park W, Kim TH, Choy YB, Park CG, Kim KH, Lee W. Lee Y, et al. Among authors: park j. Biomed Pharmacother. 2025 Jan 10:117810. doi: 10.1016/j.biopha.2025.117810. Online ahead of print. Biomed Pharmacother. 2025. PMID: 39799037 No abstract available.
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial.
Ghobadi A, Bachanova V, Patel K, Park JH, Flinn I, Riedell PA, Bachier C, Diefenbach CS, Wong C, Bickers C, Wong L, Patel D, Goodridge J, Denholt M, Valamehr B, Elstrom RL, Strati P. Ghobadi A, et al. Among authors: park jh. Lancet. 2025 Jan 11;405(10473):127-136. doi: 10.1016/S0140-6736(24)02462-0. Lancet. 2025. PMID: 39798981 Clinical Trial.
Post-COVID metabolic enzyme alterations in K18-hACE2 mice exacerbate alcohol-induced liver injury through transcriptional regulation.
Park S, Lee YW, Choi S, Jo H, Kim N, Cho S, Lee E, Choi EB, Park I, Jeon Y, Noh H, Seok SH, Oh SH, Choi YK, Kwon HK, Seo JY, Nam KT, Park JW, Choi KS, Lee HY, Yun JW, Seong JK. Park S, et al. Among authors: park jw. Free Radic Biol Med. 2025 Jan 9:S0891-5849(25)00015-2. doi: 10.1016/j.freeradbiomed.2025.01.015. Online ahead of print. Free Radic Biol Med. 2025. PMID: 39798903
71,674 results
You have reached the last available page of results. Please see the User Guide for more information.